ranolazine
PolandDrugs containing this active substance
-
It is used in the treatment of angina pectoris, which manifests as chest pain or discomfort in the upper body (between the neck and the epigastrium), often triggered by physical exertion.
Form: tablets, prolonged release
Active substance Dosage ranolazine 375 mg ATC: C01EB18
Manufacturer: Farmak International Sp. z o.o.
-
It is used in the treatment of angina pectoris, which manifests as chest pain or discomfort in the upper body (between the neck and the epigastrium), often triggered by physical exertion.
Form: tablets, prolonged release
Active substance Dosage ranolazine 500 mg ATC: C01EB18
Manufacturer: Farmak International Sp. z o.o.
-
It is used in the treatment of angina pectoris, which manifests as chest pain or a feeling of discomfort in the upper body (between the neck and the epigastrium), often triggered by physical exertion.
Form: tablets, prolonged release
Active substance Dosage ranolazine 750 mg ATC: C01EB18
Manufacturer: Farmak International Sp. z o.o.
-
The medicine is used to treat angina pectoris, which is characterized by chest pain or a feeling of discomfort in the upper body (between the neck and the epigastrium), often triggered by physical exertion.
Form: tablets, prolonged release
Active substance Dosage ranolazine 375 mg ATC: C01EB18
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to treat angina pectoris, which is characterized by chest pain or discomfort in the upper body (between the neck and the epigastrium), often triggered by physical exertion.
Form: tablets, prolonged release
Active substance Dosage ranolazine 500 mg ATC: C01EB18
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to treat angina pectoris, which is characterized by chest pain or a feeling of discomfort in the upper body (between the neck and the epigastrium), often triggered by physical exertion.
Form: tablets, prolonged release
Active substance Dosage ranolazine 750 mg ATC: C01EB18
Manufacturer: Adamed Pharma S.A.